Brain Metastases

A Randomized Phase III Trial of Memantine and Whole-Brain Radiotherapy with or without Hippocampal Avoidance in Patients with Brain Metastases (NRG-CC001) 

Please contact Jamie ford or Caroline Holcomb at (520) 626-6800 for further information regarding our clinical trials.

An Institutional Review Board responsible for human subjects research at The University of Arizona reviewed this research project and found it to be acceptable, according to applicable state and federal regulations and University policies designed to protect the rights and welfare of participants in research.